Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair

Biomaterials

Volumn 32, Issue 9, 2011, Pages 2424-2431

  Ye, Lei ^a   Zhang, Wei ^a   Su, Li Ping ^a   Haider, Husnain K ^b   Poh, Kian Keong ^c,d   Galupo, Mary J ^c   Songco, Geronica ^c   Ge, Ruo Wen ^a   Tan, Huay Cheem ^c,d   Sim, Eugene K W ^e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Cardiac repair; Hypoxia; Myocardial infarction; Skeletal myoblast; VEGF

Indexed keywords

CARDIAC REPAIR; HYPOXIA; MYOBLASTS; MYOCARDIAL INFARCTION; VEGF;

ANIMALS; BLOOD; BLOOD VESSELS; GENE THERAPY; GENE TRANSFER; HEART; HEMODYNAMICS; NANOPARTICLES; REPAIR; WALLS (STRUCTURAL PARTITIONS);

GENE EXPRESSION;

CYCLOSPORIN; NANOPARTICLE; POLYETHYLENEIMINE; VASCULOTROPIN 165;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CARDIAC GRAFT REJECTION; CELL HYPOXIA; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; ENGRAFTMENT; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEART BLOOD VESSEL; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; MALE; MYOBLAST; MYOCARDIUM REPAIR; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRANSGENE;

ANIMALS; CELL HYPOXIA; CELL SURVIVAL; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HEART FUNCTION TESTS; HUMANS; MYOBLASTS; MYOCARDIUM; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENEIMINE; RABBITS; REGIONAL BLOOD FLOW; RESPONSE ELEMENTS; TRANSFECTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 78751701144     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.008     Document Type: Article

References (20)

1. Ye L., Haider Kh H., Jiang S.J., Sim E.K.W. Therapeutic angiogenesis: devising new strategies based on past experiences. Basic Res Cardiol 2004, 99:121-132.
2. Ye L., Haider Kh H., Esa W.B., Law P.K., Zhang W., Su L.P., et al. Non-viral vector based gene transfection of primary human skeletal myoblasts. Exp Biol Med 2007, 232:1477-1487.
3. Ye L., Haider Kh H., Tan R.S., Toh W.C., Law P.K., Tan W.B., et al. Transplantation of nanoparticle transfected skeletal myoblasts over-expressing vascular endothelial growth factor-165 for cardiac repair. Circulation 2007, 116:I113-I120.
4. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000, 102:898-901.
5. Bohl D., Salvetti A., Moullier P., Heard J.M. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998, 92:1512-1517.
6. Hofmann A., Nolan G.P., Blau H.M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996, 93:5185-5190.
7. Wang Y., O'Malley B.W., Tsai S.Y., O'Malley B.W. A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994, 91:8180-8184.
8. Tang Y.L., Tang Y., Zhang Y.C., Qian K.P., Shen L.P., Phillips M.I. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005, 46:1339-1350.
9. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003, 9:677-684.
10. Su H., Arakawa-Hoyt J., Kan Y.W. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002, 99:9480-9485.
11. 165 and angiopoietin-1. Eur J Heart Fail 2007, 9:15-22.
12. Ye L., Haider Kh H., Jiang S.J., Tan R.S., Toh W.C., Ge R., et al. Angiopoietin-1 induced myocardial neovascularization: a comparison between ex-vivo delivery using skeletal myobalsts vs direct viral vector injection. Eur J Heart Fail 2007, 9:458-465.
13. Ye L., Haider Kh H., Tan R.S., Su L.P., Law P.K., Zhang W., et al. Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials 2008, 29:2125-2137.
14. Ye L., Haider Kh H., Esa W.B., Su L.P., PKh Law, Zhang W., et al. Liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischemic limb disease. J Cell Mol Med 2010, 14:323-336.
15. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
16. Lungwitz U., Breunig M., Blunk T., Gȯpferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 2005, 60:247-266.
17. Fischer D., Bieber T., Li Y., Elsasser H.P., Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999, 16:1273-1279.
18. Kreiss P., Cameron B., Rangara R., Mailhe P., Aguerre-Charriol O., Airiau M., et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 1999, 27:3792-3798.
19. Shibata T., Akiyama N., Noda M., Sasai K., Hiraoka M. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int J Radiat Oncol Biol Phys 1998, 42:913-916.
20. Bouchentouf M., Benabdallah B.F., Bigey P., Yau T.M., Scherman D., Tremblay J.P. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 2008, 15:404-414.